Publications by authors named "C Gerlinger"

Claim this Profile
S
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.
Cecilie D Amdal, Ragnhild S Falk, Ahu Alanya, Michael Schlichting, Satrajit Roychoudhury, Christoph Gerlinger

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative exploration of women's experiences of vasomotor symptoms to support the content validity of patient-reported outcomes.
Claudia Haberland, Melissa Barclay, Sophie Whyman, Asha Lehane, Adam Gater, Christoph Gerlinger

J Patient Rep Outcomes· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric validation of the severity of chronic cough diary, leicester cough questionnaire, and a cough severity visual analogue scale in patients with refractory chronic cough.
Andrew Trigg, Nathan Clarke, Christoph Gerlinger, Ulrike Krahn, Adam Gater

J Patient Rep Outcomes· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric evaluation of the HFDD, PROMIS SD SF 8b, and MENQOL questionnaire in women experiencing vasomotor symptoms associated with menopause.
Andrew Trigg, Melissa Barclay, Sophie Whyman, Asha Lehane, Helena Bradley, Christoph Gerlinger

J Patient Rep Outcomes· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision-Making Criteria and Methods for Initiating Late-Stage Clinical Trials in Drug Development From a Multi-Stakeholder Perspective: A Scoping Review.
Ce Jiang, Céline Beji, Sonia Zebachi, Ghinwa Y Hayek, Aysun Cetinyurek-Yavuz, Christoph Gerlinger

Clin Pharmacol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis